People In Brief
This article was originally published in The Tan Sheet
Executive Summary
Former FDA Chief Counsel Tyler joins Venable; Perrigo appoints de Velarde as regulatory affairs manager; USP shakes up its executive team; Neutra Corp. names Morrissey president and CEO; more people in brief
You may also be interested in...
Tyler's Departure As FDA Chief Counsel Leaves Another Chair To Fill
Ralph Tyler is leaving FDA 18 months after taking the helm as the agency's chief counsel.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.